Journal article
The Economic Costs of Early Stage Prostate Cancer
Abstract
The economic costs of early stage prostate cancer are significant, and will likely increase as the proportion of older men grows in the population of industrialised nations. In the US, total costs have been estimated to range from $US1.72 billion to $US4.75 billion annually (1990 costs). Costs related to early stage prostate cancer arise from screening, staging and treatment. Cost-effectiveness models of population-based prostate cancer …
Authors
Saigal CS; Litwin MS
Journal
PharmacoEconomics, Vol. 20, No. 13, pp. 869–878
Publisher
Springer Nature
Publication Date
November 2002
DOI
10.2165/00019053-200220130-00001
ISSN
1170-7690